Aqua Bio Technology — Major Shareholding Notification 2023

Aug 3, 2023

DISCLOSURE OF LARGE SHAREHOLDING - DIRIGENT AS

DISCLOSURE OF LARGE SHAREHOLDING - DIRIGENT AS

3.8.2023 22:52:52 CEST | Aqua Bio Technology ASA | Major shareholding

notifications

Reference is made to the stock exchange announcements made by Aqua Bio

Technology ASA ("ABT" or the "Company") on 23 July 2023 regarding the Company

entering into an agreement in principle with the shareholders of Skinteam Norge

AS (the "Sellers") ("Skinteam") and the stock exchange announcements on 23 and

24 July 2023 regarding the Private Placement and the contemplated Subsequent

Offering as described therein. Reference is furthermore made to the stock

exchange notice earlier today, 3 August 2023, regarding entry into of a final

agreement for the Company's acquisition of Skinteam, which also included

information on the Company having secured voting undertakings from shareholders

representing more than 2/3 of the shares in the Company to where they have

undertaken to vote in favour of all resolutions necessary to implement the

Private Placement and the contemplated Subsequent Offering in the upcoming

extraordinary general meeting (the "EGM") that will be held on 24 August 2023.

As a consequence of the voting undertakings, the conditions for completion of

the Private Placement will be satisfied and it is therefore considered to

correct to disclose the change in shareholding at this time.

Dirigent AS was allocated 3,058,211 new Shares in the Private Placement. The

share capital increase relating to the Private Placement will be approved by an

extraordinary general meeting of the Company, to be held on 24 August 2023.

Following issuance of these new shares, and upon registration of the

corresponding share capital increase in the Norwegian Register of Business

Enterprises and subsequent delivery of such shares, Dirigent AS will hold a

total of 3,058,211 shares in the Company, representing 6.68 % of the total

number of shares and voting rights.

The disclosure obligation was triggered by Dirigent AS crossing above the 5 %

threshold of total number of voting rights and shares in the Company.

This information is subject to the disclosure requirements pursuant to Sections

4-2 and 5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2523/3499/Download%20announcement

%20as%20PDF.pdf